Who Is ASKP3?

The American Society of Ketamine Physicians, Psychotherapists, and Practitioners is a non-profit group of professionals dedicated to the safe clinical use of ketamine for mental health disorders and pain conditions.
 

ASKP3 Mission Statement:

An interdisciplinary community of collaborative practitioners led by experts providing education and ethical standards for patient care with ketamine and emerging treatments.

ASKP3 Vision Statement

Our vision is to advance the treatment of mental and physical health through the use of ketamine by:

  • Establishing scientific, ethical and transparent standards among practitioners;
  • Advancing the quality of care through the furthering of knowledge, the exchange of ideas, and research;
  • Fostering multidisciplinary collaboration to improve patient outcomes;
  • Educating the clinical communities about all aspects of this treatment modality;
  • Building awareness and understanding among the general population, legislators, regulators and payers; and
  • Welcoming relationships that support the development of other psychedelic therapies.

2023 ASKP3 Proposed Bylaws Amendments

Throughout the year, the ASKP3 Board of Directors closely reviewed the Society’s Bylaws and identified several proposed amendments. While the amendments are largely housekeeping in nature, all amendments require a vote by the ASKP3 membership. The Bylaws must receive a minimum of ballots from ten percent (10%) of the members eligible to vote in order for a quorum to be met. ASKP3 currently has 463 members, so 47 members must return a ballot in order to meet the required quorum. Click here for more information and to view the Bylaws.